[Progress on thrombolytic treatment].
Kazama
M
M
D004338:Drug Combinations; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000188:drug therapy*; D010958:Plasminogen / Q000627:therapeutic use; D011486:Protein C / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D004338:Drug Combinations; D011486:Protein C; C049423:streptokinase-plasminogen complex; D010958:Plasminogen; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator